Perla Bandini: Genetic and Functional Insights into Inherited Platelet Dysfunction
Perla Bandini, Predoctoral Researcher at Blood and Tissue Bank in Barcelona, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“We are excited to share that the Laboratory of Congenital Coagulopathies has published a new research letter in the British Journal of Haematology:
‘Co-inheritance of ITGA2B and TUBB1 variants in a family reveals distinct genetic contributions to platelet dysfunction.’
In this study, we report a proband presenting macrothrombocytopenia and bleeding, in whom two candidate variants in TUBB1 and ITGA2B were identified by Whole-exome sequencing.
Through extensive family segregation analysis and RNA sequencing, we were able to unravel the contribution of each variant to the phenotype observed in the proband and her family.
Our findings highlight:
- The first reported case of oligogenic inheritance involving TUBB1 and ITGA2B.
- The first described family with Bleeding Disorder Platelet Type 16, caused by an autosomal dominant ITGA2B variant, presenting with variable bleeding severity but notably without macrothrombocytopenia.
This work underscores the importance of combining genetic and functional approaches to better understand complex cases of inherited platelet disorders.
Congratulations to all co-authors and collaborators involved in this work!”
Title: Co-inheritance of ITGA2B and TUBB1 variants in a family reveals distinct genetic contributions to platelet dysfunction
Authors: Perla Bandini, Nina Borràs, Laura Martin-Fernandez, Nuria Fernández-Mosteirín, Maria Reyes Aguinaco, Olga Benítez, Natàlia Comes, Lorena Ramírez, Noemí González, Carina Lera, Carme Altisent, Francisco Vidal, Irene Corrales
Read the Full Article on British Journal of Haematology

See more in the gallery.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 27, 2026, 17:43Heghine Khachatryan: Persistent Risks of Venous Thromboembolism in Pregnancy and Postpartum
-
Mar 27, 2026, 17:42Mahesan Subramaniam: Scientists Develop Antibody to Block Epstein-Barr Virus Infection
-
Mar 27, 2026, 17:39Lucie Tvrdá: Missing Data Could Themselves Be Used as Predictors of Stroke Outcomes
-
Mar 27, 2026, 17:31José Antonio García Erce: Update of NICE Recommendations On Blood Transfusion
-
Mar 27, 2026, 17:30Improving the Diagnosis and Care of Bleeding Disorders in Ecuador – WFH
-
Mar 27, 2026, 17:24Timo Siepmann: Does Stroke Origin Change How IV Thrombolysis Helps During Thrombectomy?
-
Mar 27, 2026, 17:19Ahmed Koriesh: Would You Start DAPT If the Patient Presents After 24 Hours?
-
Mar 27, 2026, 17:17Ifeanyichukwu Ifechidere: Understanding the Sensitivity and Specificity of D-Dimer
-
Mar 27, 2026, 17:15Wolfgang Miesbach: The Benefit with Hemophilia Rebalancing Agents Is Real, But So Are The Open Questions